Geneos Wealth Management’s Rockwell Medical RMTI Stock Holding History

Geneos Wealth Management’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-81	Closed	-$4K	–	2756
2022 Q1	$4K	Hold	81	–	–	﹤0.01%	2422
2021 Q4	$3K	Hold	81	–	–	﹤0.01%	2538
2021 Q3	$5K	Hold	81	–	–	﹤0.01%	2466
2021 Q2	$7K	Sell	81 -24	-23%	-$2.48K	﹤0.01%	2346
2021 Q1	$11K	Buy	105 +2	+2%	+$296	﹤0.01%	2352
2020 Q4	$10K	Buy	103 +22	+27%	+$2.46K	﹤0.01%	2227
2020 Q3	$9K	Hold	81	–	–	﹤0.01%	1994
2020 Q2	$15K	Hold	81	–	–	﹤0.01%	1750
2020 Q1	$19K	Hold	81	–	–	﹤0.01%	1537
2019 Q4	$20K	Sell	81 -24	-23%	-$6.04K	﹤0.01%	1693
2019 Q3	$34K	Hold	105	–	–	﹤0.01%	1366
2019 Q2	$34K	Hold	105	–	–	﹤0.01%	1381
2019 Q1	$65K	Hold	105	–	–	﹤0.01%	1020
2018 Q4	$28K	Sell	105 -1	-0.9%	-$398	﹤0.01%	1355
2018 Q3	$49K	Hold	106	–	–	﹤0.01%	1182
2018 Q2	$57K	Hold	106	–	–	﹤0.01%	989
2018 Q1	$60K	Hold	106	–	–	0.01%	929
2017 Q4	$68K	Buy	+106	New	+$74.7K	0.01%	882
2016 Q3	–	Sell	-1	Closed	-$1K	–	1991
2016 Q2	$1K	Hold	1	–	–	﹤0.01%	1763
2016 Q1	$1K	Buy	+1	New	+$785	﹤0.01%	1746

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Geneos Wealth Management's RMTI Position: Q2 2022 in Review

Geneos Wealth Management sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 81 shares — an estimated $4K sold.

Geneos Wealth Management first reported a position in RMTI in Q1 2016 and held it in 20 quarters. The position peaked at $68K in Q4 2017. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

Geneos Wealth Management reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
Geneos Wealth Management sold 81 Rockwell Medical shares in Q2 2022, an estimated $4K.
Geneos Wealth Management first reported a position in Rockwell Medical in Q1 2016 and held it in 20 quarters.
Geneos Wealth Management's Rockwell Medical position peaked at $68K in Q4 2017.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.